Skip to main content
. 2015 Oct 27;293:469–484. doi: 10.1007/s00404-015-3914-8

Table 3.

Medicinal products containing dequalinium chloride (DQC) reported in the treatment of vaginal infections

Medicinal product Formulation References
Dequadin® Vaginal pessary 10 mg [88, 95, 99]
Dequavagyn® Ovule 50 mg; controlled release for 8–10 days [34, 96]
Dequavagyn® Cream 20 mg/10 g cream; controlled release for 8–10 days [34, 9194, 96, 97, 100]
Oestro-Dequavagyn® Cream 20 mg/10 g cream; controlled release for 8–10 days
+0.15 mg estriol/10 g cream
[93, 98]
Oestro-Dequavagyn® Cream 20 mg/10 g cream; controlled release for 8–10 days
+2 mg Estriol/10 g cream
[93]
Gyken® Ovule 20 mg [28]
Eriosept® Vaginal foam 100 mg/100 g [101]
Fluomizin® 10 mg vaginal tablet [26, 32]